Functional MRI of Basal Ganglia Responsiveness to Levodopa in Parkinsonian Rhesus Monkeys
暂无分享,去创建一个
Anders H. Andersen | Malcolm J. Avison | Don M. Gash | A. Andersen | M. Avison | Zhiming Zhang | W. Cass | D. Gash | A. Ovadia | Zhiming Zhang | Aliza Ovadia | Qun Chen | Wayne A. Cass | Qun-Yan Chen | Aliza Ovadia | Qun Chen
[1] M. Muenter,et al. L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects. , 1971, Mayo Clinic proceedings.
[2] B. Siesjö,et al. Excessive increase in oxygen uptake and blood flow in the brain during amphetamine intoxication. , 1976, Acta Physiologica Scandinavica.
[3] J. Mcculloch,et al. Cerebral circulation: effect of stimulation and blockade of dopamine receptors. , 1977, The American journal of physiology.
[4] R. Young,et al. Different behavioral responses tol-DOPA after anterolateral or posterolateral hypothalamic injections of 6-hydroxydopamine , 1977, Brain Research.
[5] B. Siesjö,et al. Circulatory and metabolic effects in the brain induced by amphetamine sulphate. , 1978, Acta physiologica Scandinavica.
[6] W J Schwartz,et al. Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat. , 1979, Science.
[7] J. Korf,et al. The Neurobiology of dopamine , 1979 .
[8] G. Breese,et al. Role of monoamine neural systems in L-dihydroxyphenylalanine-stimulated activity. , 1979, The Journal of pharmacology and experimental therapeutics.
[9] B. Sahakian,et al. Circling behavior in rats with partial, unilateral nigro-striatal lesions: Effect of amphetamine, apomorphine, and DOPA , 1980, Pharmacology Biochemistry and Behavior.
[10] Louis Sokoloff,et al. Activity‐dependent Energy Metabolism in Rat Posterior Pituitary Primarily Reflects Sodium Pump Activity , 1980, Journal of neurochemistry.
[11] J. Mcculloch,et al. Cerebral circulatory and metabolic effects of piribedil. , 1980, European journal of pharmacology.
[12] L. Sokoloff,et al. Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system. , 1981, Federation proceedings.
[13] J. Mcculloch,et al. Effect of Apomorphine on the Relationship between Local Cerebral Glucose Utilization and Local Cerebral Blood Flow (with an Appendix on its Statistical Analysis) , 1982, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[14] R. C. Collins,et al. Effects of dopaminergic stimulation on functional brain metabolism in rats with unilateral substantia nigra lesions , 1983, Brain Research.
[15] Martin Ingvar,et al. Apomorphine-induced changes in local cerebral blood flow in normal rats and after lesions of the dopaminergic nigrostriatal bundle , 1983, Brain Research.
[16] D Comar,et al. Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease. , 1984, Journal of neurology, neurosurgery, and psychiatry.
[17] Marcus E. Raichle,et al. Regional blood flow in herniparkinsonism , 1985, Neurology.
[18] R J Wise,et al. The effects of L-DOPA on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease. , 1985, Brain : a journal of neurology.
[19] P. Goldman-Rakic,et al. Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[20] D. Jacobowitz,et al. Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). , 1986, Life sciences.
[21] J. Mcculloch,et al. Catecholamines and the relationship between cerebral blood flow and glucose use. , 1986, The American journal of physiology.
[22] G. Wooten,et al. The effects ofl-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigra , 1986, Brain Research.
[23] M. Raichle,et al. Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[24] D. Jacobowitz,et al. Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D-2 receptor density , 1986, Brain Research.
[25] C. D. Stern,et al. Handbook of Chemical Neuroanatomy Methods in Chemical Neuroanatomy. Edited by A. Bjorklund and T. Hokfelt. Elsevier, Amsterdam, 1983. Cloth bound, 548 pp. UK £140. (Volume 1 in the series). , 1986, Neurochemistry International.
[26] G. Wooten,et al. Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[27] A. Crane,et al. Changes in local cerebral glucose utilization associated with Parkinson's syndrome induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the primate. , 1987, Life sciences.
[28] K. Jellinger,et al. Overview of morphological changes in Parkinson's disease. , 1987, Advances in neurology.
[29] A. Crane,et al. Local cerebral metabolic effects of L-dopa therapy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[30] P. Bédard,et al. Relation between brain dopamine loss and D2 dopamine receptor density in MPTP monkeys , 1988, Neuroscience Letters.
[31] T. Di Paolo,et al. Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys. , 1988, European journal of pharmacology.
[32] Ian Q. Whishaw,et al. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats , 1988, Brain Research.
[33] D. Tank,et al. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[34] E. Abercrombie,et al. Effects ofl-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats , 1990, Brain Research.
[35] J G Nutt,et al. Levodopa‐induced dyskinesia , 1990, Neurology.
[36] S. Ogawa. Brain magnetic resonance imaging with contrast-dependent oxygenation , 1990 .
[37] C. Gerfen,et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. , 1990, Science.
[38] S. Boyce,et al. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. II. Unilateral intra-carotid infusion of MPTP in the monkey (Macaca fascicularis) , 1990, Brain Research.
[39] J. Hsiao,et al. In vivo changes of catecholamines in hemiparkinsonian monkeys measured by microdialysis , 1990, Experimental Neurology.
[40] T. Di Paolo,et al. Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists. , 1990, European journal of pharmacology.
[41] R. Schwartzman,et al. Dopamine receptor changes in untreated and (+)-PHNO-treated MPTP parkinsonian primates , 1991, Brain Research.
[42] O. Rascol,et al. Subcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanisms. , 1991, British journal of clinical pharmacology.
[43] John Sharkey,et al. Acute cocaine administation: effects on local cerebral blood flow and metabolic demand in the rat , 1991, Brain Research.
[44] A. Graybiel,et al. Corticostriatal transformations in the primate somatosensory system. Projections from physiologically mapped body-part representations. , 1991, Journal of neurophysiology.
[45] O. Hornykiewicz,et al. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey , 1991, Neuroscience.
[46] I. Mitchell,et al. A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia. , 1992, Brain : a journal of neurology.
[47] K. Takahashi,et al. Local cerebral blood flow and its response to intravenous levodopa in progressive supranuclear palsy. Comparison with Parkinson's disease. , 1992, Archives of neurology.
[48] Agid Yves. Levodopa‐induced dyskinesia , 1992 .
[49] Ravi S. Menon,et al. Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[50] G. Gerhardt,et al. Clearance of Exogenous Dopamine in Rat Dorsal Striatum and Nucleus Accumbens: Role of Metabolism and Effects of Locally Applied Uptake Inhibitors , 1993, Journal of neurochemistry.
[51] M. Sambrook,et al. Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism , 1993, Brain Research.
[52] O. Hornykiewicz,et al. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. , 1993, Advances in neurology.
[53] Z. Zhang,et al. Developing a stable bilateral model of parkinsonism in rhesus monkeys , 1993, Neuroscience.
[54] R. Schwartzman,et al. Changes in brain dopamine receptors in MPTP parkinsonian monkeys followingL-dopa treatment , 1993, Brain Research.
[55] M. Filion,et al. Pathophysiology of Levodopa-Induced Dyskinesia: Changing Concepts , 1994 .
[56] F. Hyder,et al. Dynamic Magnetic Resonance Imaging of the Rat Brain during Forepaw Stimulation , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[57] T. Paolo. Modulation of brain dopamine transmission by sex steroids. , 1994 .
[58] F. Calon,et al. Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA, receptors in the striatopallidal complex , 1995, Brain Research.
[59] M. Piercey,et al. Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys. , 1995, The Journal of pharmacology and experimental therapeutics.
[60] P. Jenner,et al. Chronic L‐DOPA administration induces dyskinesias in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated common marmoset (Callithrix jacchus) , 1995, Movement disorders : official journal of the Movement Disorder Society.
[61] L. Sokoloff,et al. Selective metabolic activation by apomorphine in striosomes of denervated striatum in MPTP-induced hemiparkinsonian monkeys. , 1995, Neuroreport.
[62] Don M. Gash,et al. Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys , 1995, Neurobiology of Aging.
[63] A Villringer,et al. Coupling of brain activity and cerebral blood flow: basis of functional neuroimaging. , 1995, Cerebrovascular and brain metabolism reviews.
[64] G. Gerhardt,et al. Increased dopamine clearance in the non-lesioned striatum of rhesus monkeys with unilateral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) striatal lesions , 1995, Neuroscience Letters.
[65] T. Di Paolo,et al. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine. , 1996, Molecular pharmacology.
[66] A H Andersen,et al. Mapping drug-induced changes in cerebral R2* by Multiple Gradient Recalled Echo functional MRI. , 1996, Magnetic resonance imaging.
[67] M Hoehn-Berlage,et al. Variation of functional MRI signal in response to frequency of somatosensory stimulation in α‐chloralose anesthetized rats , 1996, Magnetic resonance in medicine.
[68] B. Hoffer,et al. Functional recovery in parkinsonian monkeys treated with GDNF , 1996, Nature.
[69] R. Todd,et al. Dynamic Changes in Striatal Dopamine D2 and D3 Receptor Protein and mRNA in Response to 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Denervation in Baboons , 1996, The Journal of Neuroscience.
[70] D. Hilt,et al. Glial cell line–derived neurotrophic factor–levodopa interactions and reduction of side effects in parkinsonian monkeys , 1997, Annals of neurology.
[71] B R Rosen,et al. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data , 1997, Magnetic resonance in medicine.
[72] M. Gado,et al. PET Measurement of Dopamine D2 Receptor-Mediated Changes in Striatopallidal Function , 1997, The Journal of Neuroscience.